Press release
Thyroid Eye Disease Market Report- Expansive Coverage on the Profit Sources
According to the latest research by InsightAce Analytic, the Thyroid Eye Disease Market Size is valued at USD 2.26 billion in 2024 and is predicted to reach USD 4.02 billion by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2893
Thyroid eye disease (TED), also referred to as Graves' orbitopathy or Graves' ophthalmopathy, is an autoimmune condition marked by inflammation and swelling of the tissues surrounding the eyes. The rising incidence of thyroid eye disease is anticipated to support market expansion over the forecast period. In addition, improvements in healthcare infrastructure, higher levels of patient adherence to treatment, and ongoing advances in therapies for autoimmune disorders are contributing positively to market growth.
Moreover, the global thyroid eye disease market is expected to present substantial revenue opportunities for industry participants, supported by increasing disposable incomes and sustained research and development (R&D) activities. Significant investments by leading market players, along with continuous technological progress in therapeutic solutions, are creating attractive growth prospects for manufacturers and suppliers operating within the thyroid eye disease market.
List of Prominent Players in the Thyroid Eye Disease Market:
• Horizon Therapeutics
• Viridian Therapeutics
• Pierre Fabre/ACELYRIN
• HanAll Biopharma/Harbour BioMed/Immunovant
• Sling Therapeutics
• Other Market Players
Market Dynamics:
Drivers-
The rising incidence of thyroid eye disease (TED) remains a key factor supporting market growth. Improved patient adherence to treatment protocols, continued advancements in therapies for autoimmune disorders, and increasing investments in research and development (R&D) are further strengthening market expansion. In addition, the growing emphasis on therapeutic innovation and enhanced access to effective treatment options is expected to positively influence the growth of the global thyroid eye disease market.
Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2893
Challenges:
Market growth is constrained by the absence of definitive curative therapies and limited disease awareness across emerging economies. The high cost associated with available treatment options also restricts broader adoption. Furthermore, the COVID-19 pandemic disrupted market dynamics through global supply chain interruptions, production slowdowns, and financial losses for key industry participants. These challenges have affected manufacturers, distributors, and retailers, creating short-term barriers to market expansion.
Regional Trends:
North America is anticipated to lead the thyroid eye disease market, driven by a high prevalence of the condition, ongoing advancements in treatment solutions, and substantial R&D investments by major industry players. The region is expected to sustain a strong compound annual growth rate (CAGR) over the forecast period. Europe also represents a significant share of the market, supported by a well-established healthcare infrastructure and the increasing adoption of innovative therapeutic approaches. The presence of prominent market participants and collaborative initiatives aimed at improving market reach further reinforces the region's position.
Recent Developments:
• In March 2024, ACELYRIN, INC. announced positive proof-of-concept results from a Phase 1⁄2 trial of lonigutamab in thyroid eye condition that is now underway. Lonigutamab is a subcutaneous (SC) humanized IgG1 monoclonal antibody that aims the insulin-like growth factor-1 receptor (IGF-1R), a known mechanism of action for thyroid eye disease treatment.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2893
Segmentation of Thyroid Eye Disease Market-
By Marketed Treatment-
• TEPEZZA (Teprotumumab)
By Pipeline Treatment-
• VRDN 001
• VB 421
• Batoclimab
• Linsitnib
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get More Information:
https://www.insightaceanalytic.com/report/thyroid-eye-disease-market/2893
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Eye Disease Market Report- Expansive Coverage on the Profit Sources here
News-ID: 4353839 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Particle Size Analysis Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Particle Size Analysis Market - (By Technology (Laser Diffraction, DLS, Imaging (Dynamic Imaging, Static Imaging), Coulter Principle, Sieving, Nanoparticle Tracking), Dispersion (Wet, Dry, Spray), End User (Pharma-Biotech, Cosmeceutical, Chemicals, Food, Academia)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Particle Size Analysis Market is valued at…
Mitochondrial-Based Therapeutics Market Report on the Untapped Growth Opportunit …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Mitochondrial-Based Therapeutics Market - (By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication (Mitochondrial Myopathy, Leber's heredity Optic Neuropathy, Leigh Syndrome, Mitochondrial DNA Depletion Syndrome, Mitochondrial Encephalomyopathy, Lactic Acidosis, Myoclonic Epilepsy with ragged red Fibres), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies)), Trends,…
Idiopathic Pulmonary Fibrosis Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Idiopathic Pulmonary Fibrosis Management Market - (By Drug Class (Pirfenidone, Nintedanib, Interferon Gammato1b), By Treatment (Oxygen Therapy, Lung Transplant), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Idiopathic Pulmonary Fibrosis Management Market…
Heparin-Induced Thrombocytopenia (HIT) Treatment Market Exclusive Report with De …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Heparin-Induced Thrombocytopenia (HIT) Treatment Market - (By Drug Types (Lepirudin, Danaparoid, Argatroban), By Test Types (Enzyme Immunoassay (EIA), Serotonin Release Assay (SRA), Enzyme-Linked Immunosorbent Assay (ELISA), Heparin-Induced Platelet Activation (HIPA) Test), By End User (Hospitals, Diagnostic Centers, Specialized Clinics, Hospital Pharmacy, Home Care Setting, Mail Order Pharmacy)), Trends, Industry Competition Analysis, Revenue and Forecast To…
More Releases for Thyroid
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Thyroid Function Test Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for thyroid function tests has witnessed substantial growth in the past few years. The market is projected to expand from $1.7 billion in 2024 to $1.81 billion in 2025, with an…
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
The Thyroid Function Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Thyroid Function Test Market Size During the Forecast Period?
The thyroid function test market has grown significantly in recent years. It is expected to grow from $1.7 billion in 2024…
Thyroid Function Test Market Report 2024 - Thyroid Function Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global Thyroid Function Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period.
Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive…
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
